R&D Trends: What's Changed in the Pharma Pipeline? Tom Heyman, President, Johnson & Johnson Innovation, JJDC; Vivek Ramaswamy, CEO, Roivant Sciences and Axovant Sciences; Daniel Teper, CEO, Immune Pharmaceuticals Moderator: Joel Marcus, CEO, Alexandria Ventures
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.